Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
June 15 2017 - 3:00AM
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today
announced that it is holding its second International Symposium on
Tissue Technologies in Berlin, Germany on June 15 - 16, 2017.
Following the success of the first International Tissue
Technologies Symposium in 2016, Integra is holding a second event,
offering a two-day scientific symposium, which will bring together
more than 100 surgeons from Europe and the United States. The 2017
International Symposium on Tissue Technologies will present an
overview of different surgical techniques used in various medical
fields, such as dermal reconstruction and regeneration, and plastic
and reconstructive procedures in breast and complex abdominal wall
repair. A faculty of world-renowned key opinion leaders will join
the meeting to share their experience and viewpoints during the
different scientific sessions and discussions.
"As a world leader in regenerative technologies, Integra is
committed to offering a best-in-class medical education platform
that will enable physicians to benefit from the experience of some
of the world's leading plastic and reconstructive surgeons," said
Stephane Corp, Integra's vice president, Tissue Technologies,
Europe.
“We share with many surgeons a strong vision of all the
scientific benefits brought by the soft tissue repair technologies.
We believe that these technologies will continue to help improve
patients' lives, and we are proud to offer a forum where
practitioners can share best practices and techniques learned from
their personal experience with patients."
About IntegraIntegra LifeSciences is dedicated
to limiting uncertainty for clinicians, so they can concentrate on
providing the best patient care. Integra offers innovative
solutions, including leading plastic and regenerative technologies,
in specialty surgical solutions, and orthopedics and tissue
technologies. For more information, please visit
www.integralife.com.
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 2016.
Forward-looking statements include, but are not limited to,
statements concerning the products and services provided by
Integra. Such forward looking statements involve risks and
uncertainties that could cause actual results to differ materially
from predicted or expected results. Among other things, the
willingness of surgical professionals to use Integra products may
affect the prospects for their use in surgical procedures. In
addition, the economic, competitive, governmental, technological
and other factors, identified under the heading "Risk Factors"
included in Item IA of Integra's Annual Report on Form 10-K for the
year ended December 31, 2016 and information contained in
subsequent filings with the Securities and Exchange Commission
could affect actual results.
Contact Information:
Media:
Marie-Anne Girel (Europe)
+33 4 37 47 59 70
marie-anne.girel@integralife.com
Laurene Isip (U.S.)
+ 609 750 7984
laurene.isip@integralife.com
Investors:
Michael Beaulieu
+ 1 609 750 2827
michael.beaulieu@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Mar 2024 to Apr 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Apr 2023 to Apr 2024